Seroepidemiology of hepatitis B, C and delta viruses in Tunisia

被引:75
作者
Triki, H
Said, N
Salah, A
Arrouji, A
BenAhmed, F
Bouguerra, A
Hmida, S
Dhahri, R
Dellagi, K
机构
[1] CTR MIL TRANSFUS SANGUINE,TUNIS,TUNISIA
[2] CTR NATL TRANSFUS SANGUINE,TUNIS,TUNISIA
关键词
hepatitis B virus; hepatitis C virus; hepatitis delta virus; seroepidemiology; Tunisia;
D O I
10.1016/S0035-9203(97)90374-6
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Serum samples from 33363 healthy people in Tunisia have been tested for serological markers of hepatitis B, C and delta viruses (HBV, HCV and HDV). Hepatitis B surface antigen (HBsAg) was detected in 6.5% of sera. The overall seroprevalence of HBV was 37.5 %. Vertical and perinatal transmission of HBV in the first 3 months of life occurred in only 0.4% of 177 mother and child pairs. HBV seroprevalence was 10.7% in infants under 5 years old and increased with age rapidly till 25 years of age and then more slowly in adulthood, reaching 54% for people aged over 40 years. HBsAg seropositivity varied throughout the country, ranging from 3% to 13% with higher prevalences in the south and central-west regions. Overall seroprevalences for HDV and HCV were 17.7% and 0.4%, respectively. HDV superinfection occurred later than HBV and increased with age in parallel with HBV. Overall, HCV and HBV infections had different geographical distributions throughout the country. The study confirmed the high prevalence of HBV infection in Tunisia; it occurs mainly in children and teenagers, and vertical and perinatal transmission of HBV does not appear to be significant. HDV superinfection is quite common in Tunisia and occurs in almost 44% of individuals infected with HBV. In contrast, seroprevalence of HCV in the Tunisian general population was low (0.4%). These results indicate differences in the distribution of the viruses and/or different routes of transmission.
引用
收藏
页码:11 / 14
页数:4
相关论文
共 27 条
[1]   SEROEPIDEMIOLOGY OF HEPATITIS-B VIRUS-INFECTION IN SAUDI-ARABIAN CHILDREN - A BASE-LINE SURVEY FOR MASS VACCINATION AGAINST HEPATITIS-B [J].
ALFALEH, FZ ;
AYOOLA, EA ;
ARIF, M ;
RAMIA, S ;
ALRASHED, R ;
ALJEFFRY, M ;
ALMOFARREH, M ;
ALKARAWI, M ;
ALSHABRAWY, M .
JOURNAL OF INFECTION, 1992, 24 (02) :197-206
[2]  
Bahri M, 1988, Tunis Med, V66, P531
[3]  
BEASLEY RP, 1983, LANCET, V2, P1099
[4]   HB VIRUS-INFECTION AND DELTA-SUPERINFECTION IN SAHELIAN AFRICA - A CASE CONTROL STUDY ON THE PREVALENCE OF LIVER-DISEASE IN 2 INTERNAL-MEDICINE UNITS IN NIAMEY (REPUBLIC-OF-NIGER) - 78 CASES [J].
CENAC, A ;
DEVELOUX, M ;
LAMOTHE, F ;
SOUBIRAN, G ;
VETTER, JM ;
SOUMANA, I ;
TREPO, C .
REVUE DE MEDECINE INTERNE, 1986, 7 (05) :465-469
[5]   HEPATITIS-C VIRUS-INFECTION IN AN AREA HYPERENDEMIC FOR HEPATITIS-B AND CHRONIC LIVER-DISEASE - THE TAIWAN EXPERIENCE [J].
CHEN, DS ;
KUO, GC ;
SUNG, JL ;
LAI, MY ;
SHEU, JC ;
CHEN, PJ ;
YANG, PM ;
HSU, HM ;
CHANG, MH ;
CHEN, CJ ;
HAHN, LC ;
CHOO, QL ;
WANG, TH ;
HOUGHTON, M .
JOURNAL OF INFECTIOUS DISEASES, 1990, 162 (04) :817-822
[6]   LOW INCIDENCE OF NON-A, NON-B POSTTRANSFUSION HEPATITIS IN LONDON CONFIRMED BY HEPATITIS-C VIRUS SEROLOGY [J].
CONTRERAS, M ;
BARBARA, JAJ ;
ANDERSON, CC ;
RANASINGHE, E ;
MOORE, C ;
BRENNAN, MT ;
HOWELL, DR ;
ALOYSIUS, S ;
YARDUMIAN, A .
LANCET, 1991, 337 (8744) :753-757
[7]   RISK-FACTORS ASSOCIATED WITH A HIGH SEROPREVALENCE OF HEPATITIS-C VIRUS-INFECTION IN EGYPTIAN BLOOD-DONORS [J].
DARWISH, MA ;
RAOUF, TA ;
RUSHDY, P ;
CONSTANTINE, NT ;
RAO, MR ;
EDELMAN, R .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1993, 49 (04) :440-447
[8]   A SURVEY OF ANTIBODIES TO HEPATITIS-C VIRUS IN ETHIOPIA [J].
FROMMEL, D ;
TEKLEHAIMANOT, R ;
BERHE, N ;
AUSSEL, L ;
VERDIER, M ;
PREUX, PM ;
DENIS, F .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1993, 49 (04) :435-439
[9]  
HESS G, 1989, LANCET, V2, P987
[10]  
HOUISSA R, 1988, Archives de l'Institut Pasteur de Tunis, V65, P53